• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本诊断检测、影像检查及药品价格下降而成本上升的矛盾现象。

The paradox of decreasing prices and increasing costs for diagnostic tests, imaging, and drugs in Japan.

作者信息

Ikegami N, Ikeda S

机构信息

Keio University.

出版信息

Int J Technol Assess Health Care. 1997 Winter;13(1):99-110. doi: 10.1017/s0266462300010266.

DOI:10.1017/s0266462300010266
PMID:9119627
Abstract

Analysis of the 1987-91 national outpatient claims data shows that the percentage of patients under going sophisticated diagnostic tests tended to increase and was greater if the hospital was larger, in the public sector, or affiliated with an university. For imaging, the percentage that had CAT scans performed increased, while the percentage undergoing x-rays using contrast medium and other tomography decreased. However, for drugs, newer and more expensive ones tended to be preferred irrespective of the providers' characteristics. Although costs arising from the shift to more expensive and sophisticated technologies have been largely contained by reducing their prices in the fee schedule, this cost-containment strategy faces structural problems. We advocate the establishment of an infra-structure that offers incentives for providers to conduct technology assessment and to use the results.

摘要

对1987 - 1991年全国门诊索赔数据的分析表明,接受复杂诊断测试的患者比例呈上升趋势,并且如果医院规模更大、属于公共部门或附属于大学,这一比例会更高。对于成像检查,进行计算机断层扫描(CAT扫描)的比例增加,而使用造影剂进行X光检查和其他断层扫描的比例下降。然而,对于药物而言,无论提供者的特征如何,更新、更昂贵的药物往往更受青睐。尽管通过在收费表中降低价格,向更昂贵和复杂技术转变所产生的成本在很大程度上得到了控制,但这种成本控制策略面临结构性问题。我们主张建立一种基础设施,为提供者进行技术评估并利用评估结果提供激励措施。

相似文献

1
The paradox of decreasing prices and increasing costs for diagnostic tests, imaging, and drugs in Japan.日本诊断检测、影像检查及药品价格下降而成本上升的矛盾现象。
Int J Technol Assess Health Care. 1997 Winter;13(1):99-110. doi: 10.1017/s0266462300010266.
2
Why medical care costs in Japan have increased despite declining prices for pharmaceuticals.为何在药品价格下降的情况下日本的医疗费用仍在上涨。
Pharmacoeconomics. 1998;14 Suppl 1:97-105. doi: 10.2165/00019053-199814001-00012.
3
Changes in the costs of treatment of selected illnesses, 1971-1981.1971年至1981年部分疾病治疗费用的变化
Med Care. 1985 Dec;23(12):1345-57. doi: 10.1097/00005650-198512000-00004.
4
The upward spiral of drug costs: a time series analysis of drugs used in the treatment of hemophilia.药物成本的上升螺旋:血友病治疗用药的时间序列分析
Thromb Haemost. 2002 Oct;88(4):545-53.
5
[Cost analysis for ambulatory patients in internal medicine].[内科门诊患者的成本分析]
Praxis (Bern 1994). 2004 Sep 8;93(37):1510-8. doi: 10.1024/0369-8394.93.37.1510.
6
Japanese healthcare system: in vitro diagnostic tests and reimbursements.
Clin Chem. 1994 Aug;40(8):1663-7.
7
Outpatient cancer drug costs: changes, drivers, and the future.门诊癌症药物费用:变化、驱动因素及未来
Cancer. 2002 Feb 15;94(4):1142-50.
8
Cost of gentamicin assays carried out by microbiology laboratories.微生物实验室进行庆大霉素检测的成本。
J Clin Pathol. 1993 Oct;46(10):890-5. doi: 10.1136/jcp.46.10.890.
9
The cost of developing imaging agents for routine clinical use.开发用于常规临床用途的成像剂的成本。
Invest Radiol. 2006 Mar;41(3):206-12. doi: 10.1097/01.rli.0000191370.52737.75.
10
[Role of laboratory medicine in medical care--from the point of view of a manager].[检验医学在医疗保健中的作用——从管理者的角度来看]
Rinsho Byori. 2003 Sep;51(9):871-7.